Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Annals of Neurology Année : 2022

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

Gian Pal
Emily Hill
  • Fonction : Auteur
Bichun Ouyang
  • Fonction : Auteur
Yuanqing Liu
  • Fonction : Auteur
Vanessa Lythe
  • Fonction : Auteur
Debra Ehrlich
  • Fonction : Auteur
Rachel Saunders-Pullman
  • Fonction : Auteur
Vicki Shanker
  • Fonction : Auteur
Susan Bressman
  • Fonction : Auteur
Roy Alcalay
  • Fonction : Auteur
Priscilla Garcia
  • Fonction : Auteur
Karen Marder
  • Fonction : Auteur
Jan Aasly
  • Fonction : Auteur
M. Maral Mouradian
  • Fonction : Auteur
Samantha Link
  • Fonction : Auteur
Marc Rosenbaum
  • Fonction : Auteur
Sharlet Anderson
  • Fonction : Auteur
Bryan Bernard
  • Fonction : Auteur
Robert Wilson
  • Fonction : Auteur
Glenn Stebbins
  • Fonction : Auteur
William Nichols
  • Fonction : Auteur
Sepehr Sani
  • Fonction : Auteur
Mitra Afshari
  • Fonction : Auteur
Leo Verhagen
  • Fonction : Auteur
Rob M.A. de Bie
  • Fonction : Auteur
Tom Foltynie
  • Fonction : Auteur
Deborah Hall
Christopher Goetz

Résumé

Objective: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. Methods: Clinical and genetic data from 12 datasets were examined. Global cognition was assessed using the Mattis Dementia Rating Scale (MDRS). Subjects were examined for mutations in GBA and categorized as GBA carriers with or without DBS (GBA+DBS+, GBA+DBS-), and noncarriers with or without DBS (GBA-DBS+, GBA-DBS-). GBA mutation carriers were subcategorized according to mutation severity (risk variant, mild, severe). Linear mixed modeling was used to compare rate of change in MDRS scores over time among the groups according to GBA and DBS status and then according to GBA severity and DBS status. Results: Data were available for 366 subjects (58 GBA+DBS+, 82 GBA+DBS-, 98 GBA-DBS+, and 128 GBA-DBS- subjects), who were longitudinally followed (range = 36-60 months after surgery). Using the MDRS, GBA+DBS+ subjects declined on average 2.02 points/yr more than GBA-DBS- subjects (95% confidence interval [CI] = -2.35 to -1.69), 1.71 points/yr more than GBA+DBS- subjects (95% CI = -2.14 to -1.28), and 1.49 points/yr more than GBA-DBS+ subjects (95% CI = -1.80 to -1.18). Interpretation: Although not randomized, this composite analysis suggests that the combined effects of GBA mutations and STN-DBS negatively impact cognition. We advise that DBS candidates be screened for GBA mutations as part of the presurgical decision-making process. We advise that GBA mutation carriers be counseled regarding potential risks associated with STN-DBS so that alternative options may be considered. ANN NEUROL 2022;91:424-435.

Dates et versions

hal-04588567 , version 1 (27-05-2024)

Identifiants

Citer

Gian Pal, Graziella Mangone, Emily Hill, Bichun Ouyang, Yuanqing Liu, et al.. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Annals of Neurology, 2022, 91 (3), pp.424-435. ⟨10.1002/ana.26302⟩. ⟨hal-04588567⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More